Average Co-Inventor Count = 2.35
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Millennium Pharmaceuticals Limited (19 from 850 patents)
2. The Brigham and Women's Hospital, Inc. (1 from 1,384 patents)
3. Millenium Pharmaceuticals, Inc. (1 from 36 patents)
20 patents:
1. 7534579 - 14273 receptor, a novel G-protein coupled receptor
2. 7482147 - Ubiquitin protease
3. 7256010 - Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor
4. 7078205 - NUCLEIC ACID SEQUENCES ENCODING MELANOMA ASSOCIATED ANTIGEN MOLECULES, AMINOTRANSFERASE MOLECULES, ATPASE MOLECULES, ACYLTRANSFERASE MOLECULES, PYRIDOXAL-PHOSPHATE DEPENDENT ENZYME MOLECULES AND USES THEREFOR
5. 7057028 - 14273 Receptor, a novel G-protein coupled receptor
6. 7029895 - 27411, a novel human PGP synthase
7. 6979564 - 80090, human fucosyltransferase nucleic acid molecules and uses thereof
8. 6972187 - OAT5 molecules and uses therefor
9. 6953682 - Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
10. 6900303 - 57658, a novel human uridine kinase and uses thereof
11. 6780627 - 22438, 23553, 25278, and 26212 novel human sulfatases
12. 6767727 - 22438, 23553, 25278, and 26212 novel human sulfatases
13. 6686185 - 25934, a novel fatty acid desaturase and uses therefor
14. 6586205 - 43239 a novel GPCR-like molecule and uses thereof
15. 6534302 - 22438, 23553, 25278, and 26212 novel human sulfatases